Andrew Park

Andrew Park

Auto-generated profile, based on publicly available information

Andrew Park

Department of Dermatology University of Texas Southwestern Medical Center Dallas Texas USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
USUri Sela
Uri Sela
CPChae Gyu Park
Chae Gyu Park
APAndrew Park
Andrew Park
POPeter Olds
Peter Olds
SWShu Wang
Shu Wang
VFVincent A. Fischetti
Vincent A. Fischetti
Cytokines secreted from dendritic cells (DCs) play an important role in the regulation of T helper (Th) cell differentiation and activation into effector cells. Therefore, controlling cytokine secretion from DCs may potentially regulate Th differentiation/activation. DCs also induce de-novo generation of regulatory T cells (Treg) that modulate the immune response. In the current study we used the mixed leukocyte reaction (MLR) to investigate the effect of allospecific Treg on IL-12, TNFα and IL-6 secretion by DCs. Treg cells were found to markedly down-regulate IL-12 secretion from DCs following stimulation with TLR7/8 agonist. This down-regulation of IL-12 was neither due to a direct suppression of its production by the DCs nor a result of marked DC death. We found that IL-12 was rather actively consumed by Treg cells. IL-12 consumption was mediated by a subpopulation of IL-12Rβ2-expressing Treg cells and was dependent on MHC class-II expressed on dendritic cells. Furthermore, IL-12 consumption by Tregs increased their suppressive effect on T cell proliferation and Th1 activation. These results provide a new pathway of Th1 response regulation where IL-12 secreted by DCs is consumed by a sub-population of IL-12Rβ2-expressing Treg cells. Consumption of IL-12 by Tregs not only reduces the availability of IL-12 to Th effector cells but also enhances the Treg immunosuppressive effect. This DC-induced IL-12Rβ2-expressing Treg subpopulation may have a therapeutic advantage in suppressing Th1 mediated autoimmunity.

18 October 2022 in Dermatologic Therapy
Verified
Journal Article
Open access
RRRasika Reddy
Rasika Reddy
APAndrew Park
Andrew Park
TVTravis Vandergriff
Travis Vandergriff
BCBenjamin F. Chong
Benjamin F. Chong

10 May 2018 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
APAndrew J. Park
Andrew J. Park
JMJulianne A. Mann
Julianne A. Mann